SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-067395
Filing Date
2018-11-09
Accepted
2018-11-09 16:11:51
Documents
76
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-18987_110q.htm 10-Q 1752946
2 EX-31.1 a18-18987_1ex31d1.htm EX-31.1 11908
3 EX-31.2 a18-18987_1ex31d2.htm EX-31.2 11257
4 EX-32.1 a18-18987_1ex32d1.htm EX-32.1 9241
  Complete submission text file 0001104659-18-067395.txt   8841689

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT neos-20180930.xml EX-101.INS 2057886
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neos-20180930.xsd EX-101.SCH 64306
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT neos-20180930_cal.xml EX-101.CAL 54294
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT neos-20180930_def.xml EX-101.DEF 306266
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT neos-20180930_lab.xml EX-101.LAB 626223
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neos-20180930_pre.xml EX-101.PRE 505852
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 181173212
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1